Coronary microvascular dysfunction in women with nonobstructive ischemic heart disease as assessed by positron...

Area of Science:

• Cardiovascular Imaging
• Nuclear Cardiology
• Women's Cardiovascular Health

Background:

• Traditional risk assessment for ischemic heart disease (IHD) relies on detecting epicardial coronary stenosis.
• Nonobstructive coronary artery disease (CAD) is frequently observed in women presenting with ischemic symptoms, potentially leading to underdiagnosis.
• Current risk stratification methods may be inadequate for women with IHD and nonobstructive CAD.

Purpose of the Study:

• To review the current applications and advancements of Positron Emission Tomography (PET) imaging.
• To highlight PET's role in evaluating IHD in women with nonobstructive CAD.
• To explore how PET can identify mechanisms beyond epicardial stenosis, such as endothelial dysfunction.

Main Methods:

• Review of existing literature on PET imaging for IHD assessment.
• Focus on studies evaluating myocardial blood flow (MBF) quantification using PET.
• Analysis of PET's utility in differentiating causes of ischemia in women with normal or nonobstructive coronary arteries.

Main Results:

• PET enables precise measurement of absolute myocardial blood flow (MBF).
• PET can identify microvascular dysfunction and other non-obstructive causes of IHD.
• This imaging modality provides insights into pathophysiology not detectable by traditional methods.

Conclusions:

• PET imaging is a valuable tool for assessing IHD in women with nonobstructive CAD.
• Quantification of MBF by PET can uncover underlying mechanisms of ischemia.
• PET enhances diagnostic accuracy and risk stratification in this specific patient group.